1-20 of 21
Hertzel C. Gerstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial

ZUBIN PUNTHAKEE, STEPHANIE HALL, NATALIA MCINNES, DIANA SHERIFALI, KATE TSIPLOVA, MAHUA GHOSH, STEWART B. HARRIS, HEATHER A. LOCHNAN, THOMAS P.P. RANSOM, RONALD J. SIGAL, TAMARA SPAIC, HERTZEL C. GERSTEIN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1870-LB
https://doi.org/10.2337/db24-1870-LB
Published: 14 June 2024
View article titled, 1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial
Meeting Abstracts

221-LB: Identification of PAM as Novel Monogenic Diabetes Gene

JAMES FEINER, NICOLAS PERROT, MICHAEL CHONG, RICKY LALI, ROBERT MORTON, PEDRUM MOHAMMADI-SHEMIRANI, SALIM YUSUF, HERTZEL C. GERSTEIN, GUILLAUME PARE, MARIE PIGEYRE
Journal: Diabetes
Diabetes 2023;72(Supplement_1):221-LB
https://doi.org/10.2337/db23-221-LB
Published: 20 June 2023
View article titled, 221-LB: Identification of PAM as Novel Monogenic Diabetes Gene
Meeting Abstracts

725-P: Protein Biomarkers Associated with Dulaglutide and Cardiovascular Events in REWIND

JONATHAN M. WILSON, GUILLAUME PARE, SHUN FU LEE, HELEN M. COLHOUN, HUI-RONG QIAN, VALENTINA PIRRO, ANASTASIA HOOVER, MARK LAKSHMANAN, GIACOMO RUOTOLO, KEVIN L. DUFFIN, HERTZEL C. GERSTEIN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):725-P
https://doi.org/10.2337/db22-725-P
Published: 01 June 2022
View article titled, 725-P: Protein Biomarkers Associated with Dulaglutide and Cardiovascular Events in REWIND
Meeting Abstracts

1276-P: Transancestral Genomic Analysis Links Dysregulation of Valine Metabolism to the Development of Heart Failure in Type 2 Diabetes

YALING TANG, MARIE PIGEYRE, XIUQIN SUN, MARIO LUCA MORIERI, HETAL SHAH, GUILLAUME PARE, HERTZEL C. GERSTEIN, KENT TAYLOR, VASAN S. RAMACHANDRAN, JEROME I. ROTTER, STEPHEN S. RICH, JAMES B. MEIGS, ALISA MANNING, JOSYF MYCHALECKYJ, ALESSANDRO DORIA, CONSORTIUM NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED)
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1276-P
https://doi.org/10.2337/db22-1276-P
Published: 01 June 2022
View article titled, 1276-P: Transancestral Genomic Analysis Links Dysregulation of Valine Metabolism to the Development of Heart Failure in Type 2 Diabetes
Meeting Abstracts

1048-P: Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence

COLE D. BENDOR, AYA BARDUGO, RAN ROTEM, ESTELA DERAZNE, HERTZEL C. GERSTEIN, DORIT TZUR, ORIT PINHAS-HAMIEL, AVISHAI M. TSUR, TALI CUKIERMAN-YAFFE, YAEL LEBENTHAL, ARNON AFEK, GABRIEL CHODICK, GILAD TWIG
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1048-P
https://doi.org/10.2337/db22-1048-P
Published: 01 June 2022
View article titled, 1048-P: Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence
Meeting Abstracts

731-P: Metabolite Biomarkers and Cardiovascular Events in REWIND: A Post Hoc Analysis

VALENTINA PIRRO, GUILLAUME PARE, SHUN FU LEE, HELEN M. COLHOUN, YANZHU LIN, JONATHAN M. WILSON, HUI-RONG QIAN, ANASTASIA HOOVER, KEVIN L. DUFFIN, HERTZEL C. GERSTEIN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):731-P
https://doi.org/10.2337/db22-731-P
Published: 01 June 2022
View article titled, 731-P: Metabolite Biomarkers and Cardiovascular Events in REWIND: A Post Hoc Analysis
Meeting Abstracts

162-LB: Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome—The ELIXA Biomarker Study

HERTZEL C. GERSTEIN, SIBYLLE HESS, BRIAN CLAGGETT, JEAN-CLAUDE TARDIF, MARC A. PFEFFER
Journal: Diabetes
Diabetes 2022;71(Supplement_1):162-LB
https://doi.org/10.2337/db22-162-LB
Published: 01 June 2022
View article titled, 162-LB: Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome—The ELIXA Biomarker Study
Meeting Abstracts

1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood

INBAR ZUCKER, YAIR ZLOOF, AYA BARDUGO, AVISHAI M. TSUR, MIRI LUTSKI, YARON COHEN, TALI CUKIERMAN-YAFFE, NOGA MINSKY, ESTELA DERAZNE, DORIT TZUR, CHELI MELZER COHEN, ORIT PINHAS-HAMIEL, GABRIEL CHODICK, ITAMAR RAZ, ARNON AFEK, HERTZEL C. GERSTEIN, AMIR TIROSH, GILAD TWIG
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1263-P
https://doi.org/10.2337/db22-1263-P
Published: 01 June 2022
View article titled, 1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood
Meeting Abstracts

1102-P: Identifying Blood Biomarkers for Type 2 Diabetes Subtyping: A Report from the ORIGIN Trial

MARIE PIGEYRE, HERTZEL C. GERSTEIN, LEIF GROOP, SIBYLLE HESS, GUILLAUME PARE
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1102-P
https://doi.org/10.2337/db22-1102-P
Published: 01 June 2022
View article titled, 1102-P: Identifying Blood Biomarkers for Type 2 Diabetes Subtyping: A Report from the ORIGIN Trial
Meeting Abstracts

190-LB: Vaspin—A Novel Predictor of Type 2 Diabetes Risk

HARRY WANG, MICHAEL CHONG, NICOLAS PERROT, JAMES FEINER, SIBYLLE HESS, SALIM YUSUF, HERTZEL C. GERSTEIN, GUILLAUME PARE, MARIE PIGEYRE
Journal: Diabetes
Diabetes 2022;71(Supplement_1):190-LB
https://doi.org/10.2337/db22-190-LB
Published: 01 June 2022
View article titled, 190-LB: Vaspin—A Novel Predictor of Type 2 Diabetes Risk
Meeting Abstracts

187-OR: Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in the ACCORD Trial

JURAJ KOSKA, HERTZEL C. GERSTEIN, PAUL J. BEISSWENGER, PETER REAVEN
Journal: Diabetes
Diabetes 2021;70(Supplement_1):187-OR
https://doi.org/10.2337/db21-187-OR
Published: 01 June 2021
View article titled, 187-OR: Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in the ACCORD Trial
Meeting Abstracts

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

NATALIA MCINNES, STEPHANIE HALL, HEATHER A. LOCHNAN, STEWART B. HARRIS, ZUBIN PUNTHAKEE, RONALD J. SIGAL, IRENE HRAMIAK, MOHAMMED AZHARUDDIN, JOANNE F. LIUTKUS, JEAN-FRANÇOIS YALE, FARAH SULTAN, ADA C. SMITH, ROSE E. OTTO, DIANA SHERIFALI, YAN YUN LIU, HERTZEL C. GERSTEIN, REMIT-IGLARLIXI COLLABORATIVE GROUP
Journal: Diabetes
Diabetes 2021;70(Supplement_1):677-P
https://doi.org/10.2337/db21-677-P
Published: 01 June 2021
View article titled, 677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial
Meeting Abstracts

95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada

IRENE HRAMIAK, HERTZEL C. GERSTEIN, LAWRENCE A. LEITER, JEAN-FRANÇOIS YALE, HARPREET S. BAJAJ, JOHN A. STEWART, MARIE-JOSEE TOUTOUNJI, STEWART B. HARRIS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):95-LB
https://doi.org/10.2337/db21-95-LB
Published: 01 June 2021
View article titled, 95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada
Meeting Abstracts

356-OR: Effect of Dulaglutide on Kidney Function–Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial

JONATHAN E. SHAW, FADY T. BOTROS, RALEIGH MALIK, CHARLES ATISSO, HELEN M. COLHOUN, HERTZEL C. GERSTEIN
Journal: Diabetes
Diabetes 2020;69(Supplement_1):356-OR
https://doi.org/10.2337/db20-356-OR
Published: 01 June 2020
View article titled, 356-OR: Effect of Dulaglutide on Kidney Function–Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial
Meeting Abstracts

944-P: HbA1c Change Is Associated with Retinopathy Outcomes during GLP-1RA CVOT Follow-Up

ANGELYN BETHEL, RAFAEL DIAZ, NOELIA CASTELLANA, HERTZEL C. GERSTEIN, MARK LAKSHMANAN
Journal: Diabetes
Diabetes 2020;69(Supplement_1):944-P
https://doi.org/10.2337/db20-944-P
Published: 01 June 2020
View article titled, 944-P: HbA1c Change Is Associated with Retinopathy Outcomes during GLP-1RA CVOT Follow-Up
Meeting Abstracts

924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND

HELEN M. COLHOUN, CLINTON HASENOUR, MATTHEW C. RIDDLE, KELLEY BRANCH, MANIGE KONIG, CHARLES ATISSO, MARK LAKSHMANAN, REEMA MODY, HERTZEL C. GERSTEIN
Journal: Diabetes
Diabetes 2020;69(Supplement_1):924-P
https://doi.org/10.2337/db20-924-P
Published: 01 June 2020
View article titled, 924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND
Meeting Abstracts

130-OR: Effects of Intensive Risk Factor Management on Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: Findings from the ACCORD Trial

YALING TANG, HETAL SHAH, CARLOS BUENO JUNIOR, XIUQIN SUN, JOANNA MITRI, MARIA SAMBATARO, LUISA SAMBADO, HERTZEL C. GERSTEIN, VIVIAN FONSECA, ALESSANDRO DORIA, RODICA POP-BUSUI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):130-OR
https://doi.org/10.2337/db20-130-OR
Published: 01 June 2020
View article titled, 130-OR: Effects of Intensive Risk Factor Management on Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: Findings from the ACCORD Trial
Meeting Abstracts

1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

MAGNUS O. WIJKMAN, BRIAN CLAGGETT, RAFAEL DIAZ, HERTZEL C. GERSTEIN, LARS KOBER, ELDRIN LEWIS, ALDO P. MAGGIONI, EMIL WOLSK, DAVID AGUILAR, RHONDA BENTLEY-LEWIS, JOHN J. MCMURRAY, JEFFREY L. PROBSTFIELD, MATTHEW C. RIDDLE, JEAN-CLAUDE TARDIF, SCOTT SOLOMON, MARC A. PFEFFER
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1421-P
https://doi.org/10.2337/db20-1421-P
Published: 01 June 2020
View article titled, 1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event
Journal Articles

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid

Mario Luca Morieri, Hetal S. Shah, Jennifer Sjaarda, Petra A. Lenzini, Hannah Campbell, Alison A. Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi, Marcus G. Pezzolesi, Ronald J. Sigal, Guillaume Paré, Santica M. Marcovina, Daniel M. Rotroff, Elisabetta Patorno, Luana Mercuri, Vincenzo Trischitta, Emily Y. Chew, Peter Kraft, John B. Buse, Michael J. Wagner, Sharon Cresci, Hertzel C. Gerstein, Henry N. Ginsberg, Josyf C. Mychaleckyj, Alessandro Doria
Journal: Diabetes
Diabetes 2020;69(4):771–783
https://doi.org/10.2337/db19-0973
Published: 23 January 2020
View article titled, <em>PPARA</em> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid
Open the PDF for <em>PPARA</em> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid in another window
Includes: Supplementary data
Meeting Abstracts

Neighborhood Walkability and Diabetes-Related Complications

REEMA SHAH, JIN LUO, HERTZEL C. GERSTEIN, GILLIAN BOOTH
Journal: Diabetes
Diabetes 2018;67(Supplement_1):309-OR
https://doi.org/10.2337/db18-309-OR
Published: 01 July 2018
View article titled, Neighborhood Walkability and Diabetes-Related Complications